Antibacterial Agents TRIZ Cases

Covalent phage-particle conjugates enable cellular internalization of bacteriophages to treat drug-resistant intracellular infections.

Novel antibacterial compounds target penicillin-binding proteins to inhibit bacterial cell wall synthesis while avoiding mammalian toxicity.

Segmented polymeric structures into defined monomers to resolve molecular weight and stability trade-offs.

Segmented boronic ester molecules target the catalytic threonine residue, resolving specificity limits in current inhibitors.

Novel aromatic compounds with anionic groups target resistant bacteria while minimizing resistance development through simplified synthesis.

Stabilizes alcohol-free formulations using pH control to resolve acidity conflicts while maintaining tissue healing benefits.

Segmented V, D, and J gene segment construction expands antibody repertoire diversity while simplifying polyclonal mixture manufacturing.

Bismuth-thiol suspensions overcome biofilm matrix barriers to treat resistant infections while reducing host cell toxicity.

Detoxified type C culture supernatant overcomes insufficient immune stimulation from normal flora to protect sows and piglets.

Depletes guanosine nucleotides via mycophenolic acid while increasing melanin levels to treat Zika virus infections with reduced host toxicity.

Transitioning liquid vaccines to dry micropellets prevents antigen-adjuvant interactions that cause instability during storage.

Co-administering Bifidobacteria with fucosylated oligosaccharides suppresses pathogen adhesion in immune-compromised subjects.

Optimized pH ranges and chelating agents resolve stability contradictions in multi-dose topical ophthalmic formulations.

A monoclonal antibody binds to the galactan-III epitope on Klebsiella pneumoniae lipopolysaccharide O-antigen.

Oligomeric steroidal agents combine androgenic and estrogenic activities to provide male contraception while preventing bone density loss.

Strategic rare codon placement induces ribosomal stalling to ensure correct protein folding while maintaining translation efficiency.

Regioselective acylation of kanamycin with fatty acids reduces production costs while improving antifungal activity against resistant strains.

Pyridinium hydrogen sulfate catalyzes one-pot synthesis, eliminating volatile organic solvent pollution while maintaining high antimicrobial activity.

SP-D inhibitors block SIRPα signaling to restore macrophage phagocytosis, addressing antibiotic resistance in nosocomial pneumonia.

Drying antibiotic bone cement powder to under 1.0% water content prevents clumping caused by hygroscopic fosfomycin salts.

Myeloid interferon dendritic cells resolve the trade-off between high IFN-alpha production and effective T cell stimulation.

Donor-derived fecal microbiota administration prepares the recipient gut environment prior to hematopoietic stem cell transplantation.

Dual-promoter engineered probiotics deliver localized antimicrobial peptides to reduce antibiotic resistance in livestock gut environments.

Adding polyunsaturated C18 fatty acids to Leptospira cultures boosts antigenic mass, reducing production time and contamination risks.

Bithionol inhibits host caspases, blocking ricin and viral toxins that exploit shared cell death pathways.

Substituted pyridinonecarboxylic acid amides inhibit PDK1 signal enzymes, resolving the trade-off between inhibition reliability and therapeutic versatility.

Substituted pyridines modulate P2X3 receptors to resolve inadequate treatment coverage for genitourinary and inflammatory disorders.

SidC and SdcA protein fragments bind phosphoinositides to enable specific lipid detection in biological samples.

Cobetia marina biosurfactant disrupts bacterial communication networks to block pathogenic biofilm formation, avoiding antibiotic resistance development.

Conserved IcsP2 and SigA2 antigens provide broad-spectrum protection against multiple Shigella serotypes without triggering excessive inflammation.

Nanolipoprotein particles stabilize hydrophobic Chlamydia major outer membrane protein through self-assembling lipid bilayers.

Truncated CDTa and CDTb proteins form a fusion immunogen to neutralize toxins in resistant strains.

Avibactam free acid enables high-purity sodium salt production through intermediate purification steps.

Composite amine functional polyamides disrupt bacterial biofilms and reduce mucositis severity by integrating cationic and hydrophobic moieties.

Substituted 1-benzyl-cinnolin-4(1H)-one derivatives modulate CB2 receptor activity through precise structural design.

Phenyl-tetrahydronaphthalene compounds act as full agonists at human 5-HT2C receptors.

Cobalt-catalyzed C-H amidation introduces amide linkages into thiostrepton analogues to boost aqueous solubility.

ExoVII inhibitors prevent topoisomerase-DNA complex repair, restoring sensitivity of resistant bacteria to quinolone antibiotics.

An 8-membered ring compound with a dioxo-but-2-ene moiety delivers antibacterial activity against resistant strains like MRSA.

A sense oligonucleotide hybridizes with antisense RNA to stabilize and suppress iNOS mRNA translation.

Galactooligosaccharides block bacterial adhesion to prevent antibiotic-resistant infections.

Optimized fermentation and purification processes boost polysaccharide yield and vaccine stability, resolving low production efficiency.

Targeted amino acid substitutions improve GLP-1 selectivity over GIP, resolving the trade-off between dual-receptor efficacy and specificity.

Replacing thiol groups with hydroxamate moieties eliminates metabolic oxidation and non-specific binding while restoring beta-lactam antibiotic efficacy.